Troglitazone inhibits atherosclerosis in apolipoprotein E-knockout mice: Pleiotropic effects on CD36 expression and HDL

Arteriosclerosis, Thrombosis, and Vascular Biology

Volumn 21, Issue 3, 2001, Pages 372-377

  Chen, Zhong ^a   Ishibashi, Shun ^a   Perrey, Stéphane ^a   Osuga, Jun Ichi ^a   Gotoda, Takanari ^a   Kitamine, Tetsuya ^a   Tamura, Yoshiaki ^a   Okazaki, Hiroaki ^a   Yahagi, Naoya ^a   Iizuka, Yoko ^a   Shionoiri, Futoshi ^a   Ohashi, Ken ^a   Harada, Kenji ^a   Shimano, Hitoshi ^a,b   Nagai, Ryozo ^a   Yamada, Nobuhiro ^a,b  

^a UNIVERSITY OF TOKYO   (Japan)

^b UNIVERSITY OF TSUKUBA   (Japan)

Author keywords

Atherosclerosis; CD36; Lipoproteins; Peroxisome proliferator activated receptor; Thiazolidinediones

Indexed keywords

APOLIPOPROTEIN E; CD36 ANTIGEN; GLUCOSE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; INSULIN; MESSENGER RNA; OXIDIZED LOW DENSITY LIPOPROTEIN; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA; TROGLITAZONE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; CORONARY ARTERY ATHEROSCLEROSIS; DIABETES MELLITUS; DRUG MECHANISM; FOAM CELL; HYPERGLYCEMIA; HYPERINSULINEMIA; INSULIN RESISTANCE; LIPID DIET; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION;

EID: 0035097590     PISSN: 10795642     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.ATV.21.3.372     Document Type: Article

References (39)

1. Diabetes and cardiovascular disease: The framingham study
2. Banting lecture 1988: Role of insulin resistance in human disease
3. Hypertension, hypertriglyceridemia, and impaired endothelium-dependent vascular relaxation in mice lacking insulin receptor substrate-1
4. Diabetes and cardiovascular disease: The 'common soil' hypothesis
5. Insulin and atheroma: 20-Yr perspective
6. Why is insulin not a risk factor for coronary heart disease?
7. Thiazolidinediones in the treatment of insulin resistance and type II diabetes
8. Characterization of new oral antidiabetic agent CS-045: Studies in KK and ob/ob mice and Zucker fatty rats
9. Improvement in glucose tolerance and insulin resistance in obese subjects treated with troglitazone
10. Antihypertensive effects of CS-045 treatment in obese Zucker rats
11. Metabolic effects of troglitazone on fructose-induced insulin resistance in the rat
12. Troglitazone suppresses intimal formation following balloon injury in insulin-resistant Zucker fatty rats
13. Troglitazone inhibits vascular smooth muscle cell growth and intimal hyperplasia
14. PPAR-γ agonists inhibit production of monocyte inflammatory cytokines
15. The peroxisome proliferator-activated receptor-γ is a negative regulator of macrophage activation
16. Peroxisome proliferator-activated receptor activators target human endothelial cells to inhibit leukocyte-endothelial cell interaction
17. Modulation of vascular inflammation in vitro and in vivo by peroxisome proliferator-activated receptor-γ activators
18. An antidiabetic thiazolidinedione is a high affinity ligand for peroxisome proliferator-activated receptor γ (PPAR-γ)
19. Expression of the peroxisome proliferator-activated receptor γ (PPAR-γ) in human atherosclerosis and regulation in macrophages by colony stimulating factors and oxidized low density lipoprotein
20. PPAR-γ promotes monocyte/macrophage differentiation and uptake of oxidized LDL
21. Oxidized LDL regulates macrophage gene expression through ligand activation of PPAR γ
22. Spontaneous hypercholesterolemia and arterial lesions in mice lacking apolipoprotein E
23. Overexpressed lipoprotein lipase protects against atherosclerosis in apolipoprotein E knockout mice
24. Targeted disruption of the class B scavenger receptor CD36 protects against atherosclerotic lesion development in mice
25. High-density lipoprotein: The clinical implications of recent studies
26. Apolipoprotein A1 transgene corrects apolipoprotein E deficiency-induced atherosclerosis in mice
27. Regulation of apo A-1 gene expression by fibrates
28. PPAR α and PPAR γ activators direct a distinct tissue-specific transcriptional response via a PPRE in the lipoprotein lipase gene
29. Regulation of lipoprotein metabolism by thiazolidinediones occurs through a distinct but complementary mechanism relative to fibrates
30. Growth-promoting effects of diabetes and insulin on arteries: An in vivo study of rat aorta
31. Hyper-insulinemia produces both sympathetic neural activation and vasodilation in normal humans
32. Insulin directly reduces platelet sensitivity to aggregating agents: Studies in vitro and in vivo
33. Vascular biology of CD36: Roles of this new adhesion molecule family in different disease states
34. CD36 is a receptor for oxidized low density lipoprotein
35. Reduced uptake of oxidized low density lipoproteins in monocyte-derived macrophages from CD36-deficient subjects
36. CD36, a novel receptor for oxidized low-density lipoproteins, is highly expressed on lipid-laden macrophages in human atherosclerotic aorta
37. Induction of CD36 expression by oxidized LDL and IL-4 by a common signaling pathway dependent on protein kinase C and PPAR-γ
38. Peroxisome proliferator-activated receptor-α activators regulate genes governing lipoprotein metabolism, vascular inflammation and atherosclerosis
39. Inhibition of oxidation of low density lipoprotein by troglitazone